Mrs Holli Dezaun Waller, DO | |
3700 South Main Street, Blacksburg, VA 24060 | |
(540) 953-5445 | |
(540) 953-5453 |
Full Name | Mrs Holli Dezaun Waller |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 14 Years |
Location | 3700 South Main Street, Blacksburg, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053622167 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0116022785 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hca Houston Healthcare Tomball | Tomball, TX | Hospital |
Memorial Hermann Hospital System | Houston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Premier Provider Health Pa | 2264531276 | 21 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.
Researchers in Finland have conducted a study showing that the neutralizing bodies generated following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – generally persist for at least a year.
A six country clinical study of more than 1,100 hospitalized COVID-19 patients who required high-flow nasal cannula oxygen therapy suggests that prone positioning (rotating patients with severe breathing issues so they are face down) soon after admission can significantly reduce the need for mechanical ventilation.
AMAG Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron therapy, for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
› Verified 7 days ago
Entity Name | Regional Employee Assistance Program Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649232984 PECOS PAC ID: 1557260064 Enrollment ID: O20040612000731 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.
Researchers in Finland have conducted a study showing that the neutralizing bodies generated following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – generally persist for at least a year.
A six country clinical study of more than 1,100 hospitalized COVID-19 patients who required high-flow nasal cannula oxygen therapy suggests that prone positioning (rotating patients with severe breathing issues so they are face down) soon after admission can significantly reduce the need for mechanical ventilation.
AMAG Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron therapy, for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
› Verified 7 days ago
Entity Name | Premier Provider Health Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013397066 PECOS PAC ID: 2264531276 Enrollment ID: O20070615000236 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.
Researchers in Finland have conducted a study showing that the neutralizing bodies generated following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – generally persist for at least a year.
A six country clinical study of more than 1,100 hospitalized COVID-19 patients who required high-flow nasal cannula oxygen therapy suggests that prone positioning (rotating patients with severe breathing issues so they are face down) soon after admission can significantly reduce the need for mechanical ventilation.
AMAG Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron therapy, for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Holli Dezaun Waller, DO 6326 Stonewood Pointe Ln., Houston, TX 77066 Ph: (281) 300-9849 | Mrs Holli Dezaun Waller, DO 3700 South Main Street, Blacksburg, VA 24060 Ph: (540) 953-5445 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.
Researchers in Finland have conducted a study showing that the neutralizing bodies generated following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – generally persist for at least a year.
A six country clinical study of more than 1,100 hospitalized COVID-19 patients who required high-flow nasal cannula oxygen therapy suggests that prone positioning (rotating patients with severe breathing issues so they are face down) soon after admission can significantly reduce the need for mechanical ventilation.
AMAG Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron therapy, for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
› Verified 7 days ago
Dr. Michael Howard Clary, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3700 S Main St, Suite A, Blacksburg, VA 24060 Phone: 540-443-7187 Fax: 540-443-7182 | |
Jason Le, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1691 Innovation Dr Ste 2100, Blacksburg, VA 24060 Phone: 540-232-8405 | |
David Woodson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Gilbert St, Blacksburg, VA 24060 Phone: 540-961-8040 Fax: 540-961-9466 | |
Pete A. Guerra, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 S Main St Ste D, Blacksburg, VA 24060 Phone: 540-418-1910 | |
Crystal Downer, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3700 S Main St Ste 1a, Blacksburg, VA 24060 Phone: 540-443-7180 Fax: 540-443-3725 | |
Andrea Lynn Hall, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1645 North Main Street, Blacksburg, VA 24060 Phone: 540-552-1246 Fax: 540-552-1247 |